
Research discoveries and scientific and clinical wins from Duke.
Research discoveries and scientific and clinical wins from Duke.
Research discoveries and scientific and clinical wins from Duke.
Breakthroughs
A Duke University School of Medicine study published in JAMA Ophthalmology found that a noninvasive retinal scan performed on very preterm infants in the NICU can predict cognitive, motor, and behavioral outcomes at age 2, potentially enabling earlier intervention for developmental delays.

Breakthroughs
Duke's Jonathan Campbell presented evidence at ADA 2026 that glucagon, not just GLP-1, may be a key driver behind the remarkable efficacy of triple-agonist obesity drugs like retatrutide, which produced up to 30% body weight loss in Phase 3 trials.


Breakthroughs
A Duke University School of Medicine study published in JAMA Ophthalmology found that a noninvasive retinal scan performed on very preterm infants in the NICU can predict cognitive, motor, and behavioral outcomes at age 2, potentially enabling earlier intervention for developmental delays.

Breakthroughs
A Duke University School of Medicine study published in JAMA Ophthalmology found that a noninvasive retinal scan performed on very preterm infants in the NICU can predict cognitive, motor, and behavioral outcomes at age 2, potentially enabling earlier intervention for developmental delays.
No more articles in this section for now.
©2026 Duke Innovation Digest
Powered by Surround Sound Media
©2026 Duke Innovation Digest
Powered by Surround Sound Media
©2026 Duke Innovation Digest
Powered by Surround Sound Media